ArticleInternational journal of retina and vitreous2025
New minimally invasive technique for repositioning of a subluxated retropupillary iris-claw IOL using needle-assisted fixation.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis paper presents a modification of the needle-assisted retropupillary fixation technique for iris-claw intraocular lenses (IOLs). We introduce a novel, minimally invasive reenclavation technique for managing subluxated retropupillary iris-claw IOLs.
methodsThe technique was successfully performed on four patients diagnosed with subluxated retropupillary iris-claw IOLs. This approach involved a novel, minimally invasive reenclavation technique that utilized three needles: one long, straight translimbal needle crossing the anterior chamber and two needles introduced through the pars plana to reposition and securely reenclavate the IOL.
resultsAll patients experienced immediate and significant visual recovery, with their baseline visual acuities reestablished postoperatively. Importantly, no post-operative complications were observed during the six-month follow-up period, highlighting the safety and efficacy of the technique.
conclusionOur novel, minimally invasive technique for reenclavation of iris-claw IOLs, employing just three needles, eliminates the need for trocar insertion, infusion cannulas, or sutures. This approach offers significant advantages, including a shorter operative time and minimal surgical manipulation, leading to faster patient recovery and fewer complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.